Categories
Archives
Receive Email Updates
-
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
Tag Archives: The State of Patent Eligibility
XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa
In XY v. Trans Ova Genetics, Inc., Appeal No. 2019-1789 (Fed. Cir. July 31, 2020), a panel of Wallach, Plager and Stoll reversed the district court’s finding that claims to an improved method of cell sorting are patent ineligible under … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Alice, s. 101, The State of Patent Eligibility
Leave a comment
AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations”
This post will briefly discuss the Fed. Cir.’s denial of rehearing en banc – which left the modified panel opinion stand. The lengthy panel opinion has been the subject of my last three posts, and you should read them before … Continue reading
Posted in Patent Eligible Subject Matter
Tagged s. 101, s. 112, The State of Patent Eligibility
Leave a comment
CardioNet v. Infobionics: The Requirement for Improvements in Patent Eligibility
This decision, Appeal No. 2019-1149 (Fed. Cir. April 17th 2020) should have required about 13 pages and could have ended after the first paragraph under Section A. Instead, a split panel required a 23 page majority decision and a 10 … Continue reading
Solicitor General’s Briefs Encourage Supreme Court to Put s. 101 Back on Track
Earlier this year, the Supreme Court issued orders to the Solicitor General to weigh in on whether or not the Court should grant cert. in two high profile Fed. Cir. decisions: Hikma Pharm. USA Inc, v. Vanda Pharm. Inc., No. … Continue reading
Posted in Patent Eligible Subject Matter
Tagged 101, Supreme Court, The State of Patent Eligibility
Leave a comment